Literature DB >> 11702969

Effectiveness of optometrist screening for diabetic retinopathy using slit-lamp biomicroscopy.

S Prasad1, G G Kamath, K Jones, L G Clearkin, R P Phillips.   

Abstract

PURPOSE: To assess the effectiveness of optometrists as screeners for diabetic retinopathy using slit-lamp binocular indirect ophthalmoscopy through dilated pupils.
METHODS: Prospective study of a screening scheme. Screening was performed by 27 locally accredited optometrists in their practice. The referral protocol used a new simple grading system of retinopathy, especially designed for use in an optometrist screening programme. All positive referrals and 10% of negative referrals were reexamined by an ophthalmologist. Sensitivity, specificity, likelihood ratios and technical failure rates were calculated.
RESULTS: The optometrists screened 4904 people with diabetes in 18 months. 'Subthreshold' (screen negative) reports accounted for 4438 (90.5% of 4904); 429 (9.67%) of these were re-examined at secondary screening. There was disagreement regarding grading in 13 patients, of whom 5 (1.16% of 429) had sight-threatening retinopathy (STDR); this extrapolates to 52 patients if all the 4438 test-negatives had been examined. Of the 371 'threshold' patients, 112 (30.18%) were false positives; the commonest cause for false positive referral was drusen in patients with background diabetic retinopathy. The sensitivity for identification of STDR was 76% (95% CI 70% to 81%) and specificity 95% (95% CI 95% to 96%). The likelihood ratio of a positive test indicating STDR was 16.54 (95% CI 14.17 to 19.23) and that of a negative test 0.25 (95% CI 0.20 to 0.32). The technical failure rate was 0.2%.
CONCLUSIONS: Suitably trained and accredited community optometrists performed well when screening for diabetic retinopathy using slit-lamp biomicroscopy through a dilated pupil. This was facilitated by the use of simple grading and referral criteria. The sensitivity, positive likelihood ratio and specificity were high.

Entities:  

Mesh:

Year:  2001        PMID: 11702969     DOI: 10.1038/eye.2001.192

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  9 in total

1.  National screening programme for diabetic retinopathy. Screening by optometrists is better than screening by fundus photography.

Authors:  S Prasad; H Swindlehurst; L G Cleaqrkin
Journal:  BMJ       Date:  2001-10-27

2.  National screening programme for diabetic retinopathy. Digital image may be better for screening.

Authors:  Colin Clements
Journal:  BMJ       Date:  2002-04-06

3.  Capacity building for diabetic retinopathy screening by optometrists in India.

Authors:  Kim Ramasamy; Chitaranjan Mishra
Journal:  Indian J Ophthalmol       Date:  2021-03       Impact factor: 1.848

4.  Screening for diabetic retinopathy.

Authors:  D M Squirrell; J F Talbot
Journal:  J R Soc Med       Date:  2003-06       Impact factor: 18.000

5.  Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial.

Authors:  M Violato; H Dakin; U Chakravarthy; B C Reeves; T Peto; R E Hogg; S P Harding; L J Scott; J Taylor; H Cappel-Porter; N Mills; D O'Reilly; C A Rogers; S Wordsworth
Journal:  BMJ Open       Date:  2016-10-24       Impact factor: 2.692

Review 6.  Using Technology, Bioinformatics and Health Informatics Approaches to Improve Learning Experiences in Optometry Education, Research and Practice.

Authors:  Vivek K Gupta; Veer B Gupta
Journal:  Healthcare (Basel)       Date:  2016-11-15

7.  Sensitivity and specificity of Norwegian optometrists' evaluation of diabetic retinopathy in single-field retinal images - a cross-sectional experimental study.

Authors:  Vibeke Sundling; Pål Gulbrandsen; Jørund Straand
Journal:  BMC Health Serv Res       Date:  2013-01-10       Impact factor: 2.655

8.  Suspected retinopathies in Norwegian optometric practice with emphasis on patients with diabetes: a cross-sectional study.

Authors:  Vibeke Sundling; Pål Gulbrandsen; Ragnheidur Bragadottir; Leiv S Bakketeig; Jak Jervell; Jørund Straand
Journal:  BMC Health Serv Res       Date:  2008-02-08       Impact factor: 2.655

9.  Tear fluid proteomics multimarkers for diabetic retinopathy screening.

Authors:  Zsolt Torok; Tunde Peto; Eva Csosz; Edit Tukacs; Agnes Molnar; Zsuzsanna Maros-Szabo; Andras Berta; Jozsef Tozser; Andras Hajdu; Valeria Nagy; Balint Domokos; Adrienne Csutak
Journal:  BMC Ophthalmol       Date:  2013-08-07       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.